Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Industry Survey: FDA Regs Driving VC Investment Overseas

This article was originally published in The Gray Sheet

Executive Summary

An estimated 42% of U.S. venture capital firms will reduce their medical device sector investments over the next three years due to a perception that FDA regulations are cost-prohibitive, arbitrary and cumbersome, according to the latest industry survey.

You may also be interested in...



On Eve Of User Fee Reform, Some Minnesota Firms Signal Skepticism

A survey of Minnesota device executives released last week closely aligns with previous industry polls, but the timing is notable: it comes just as Congress is completing passage of a user fee reauthorization bill championed by national device groups.

Start-Up FDA? CDRH Seeks Entrepreneurial Spirit With New “In-Residence” Program

CDRH is hoping to inject a dose of start-up-firm mentality into its processes with the official launch last week of the entrepreneurs-in-residence pilot program as part of a broader FDA push to highlight its “innovation” bona fides.

Start-Up FDA? CDRH Seeks Entrepreneurial Spirit With New “In-Residence” Program

CDRH is hoping to inject a dose of start-up-firm mentality into its processes with the official launch last week of the entrepreneurs-in-residence pilot program as part of a broader FDA push to highlight its “innovation” bona fides.

Related Content

Topics

UsernamePublicRestriction

Register

MT030616

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel